Immunization with neural antigens, such as MOG, myelin basic protein (MBP), or proteolipid protein (PLP), leads to different variants of EAE that resemble the human progressive and relapsing–remitting forms of MS [92]. This evidence concerns the gene MBP and myeloid sarcoma.